Colgate-Palmolive said full-year 2024 net sales increased 3.3% to $20,101 million, and organic sales increased 7.4%. GAAP diluted earnings per share rose 27% to $3.51, and Base Business EPS increased 11% to $3.60.

1. 01

   Colgate-Palmolive said full-year 2024 net sales increased 3.3% to $20,101 million, and organic sales increased 7.4%. GAAP diluted earnings per share rose 27% to $3.51, and Base Business EPS increased 11% to $3.60.

2. 02

   The company said Q4 net sales decreased 0.1% to $4,944 million, while organic sales increased 4.3%. GAAP gross profit margin expanded 70 basis points to 60.3%, and GAAP diluted earnings per share were $0.90.

3. 03

   Colgate-Palmolive said net cash provided by operations for 2024 was $4,107 million, up 10% versus 2023. Free cash flow before dividends, after deducting capital expenditures of $561 million, was $3,546 million, and the company returned $3.4 billion to shareholders through dividends and share repurchases.

4. 04

   The company said net sales for 2025 are expected to be roughly flat, including a mid-single-digit negative impact from foreign exchange. It added that organic sales growth is expected to be within its long-term targeted range of 3% to 5%, including the impact of the planned exit from private label pet nutrition.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.